Join us at the Groupe de Métabolisme et Pharmacocinétique (GMP) Symposium to discuss your #ADME/#DMPK & #DrugInteractions research needs. With decades of experience providing products, studies, bioanalysis & consulting, we have the expertise help you achieve your research goals.

The recording and slides from “#siRNA Delivery Innovations in #HEPATOPAC for Long-Term Gene Silencing” are now available: hubs.ly/Q03NfV2Z0

Leonardo #daVinci was more than a Renaissance artist, he was a lifelong experimenter, anatomist, and observer of the human body. We’re honoring his scientific legacy with free prints of “The Seeds of Humanity” from our reimagined #ScienceArt collection: hubs.ly/Q03NfWF70

Please join us in welcoming Marco Gargano, PhD, PharmD to BioIVT as a Technical Sales Specialist, #ADME-Tox Services! Marco brings a unique blend of deep scientific and commercial experience to this role.

Learn about using #HEPATOPAC to model aspects of fatty #liverdisease to evaluate small molecules and siRNA-based approaches to modulate disease progression, including the use of high content imaging (HCI) for automating and increasing throughput: hubs.ly/Q03PhMQ80

For National #BreastCancer Awareness Month we’re sharing 2 customer studies offering insights into how tumors interact with their microenvironment—and how we might turn that knowledge into smarter, more effective #treatments: 🔗 hubs.ly/Q03PhQKs0 🔗 hubs.ly/Q03PhMBx0

From AI to next generation sequencing tools, biofluid-based diagnostics to antibody-drug conjugate innovation, and so much more, explore our #CancerResearch-focused resources highlighting the ideas, tools, and breakthroughs that are shaping #oncology: hubs.ly/Q03PhX1H0

Learn about advancements and strategies to harness the power of rheumatoid #arthritis cells to accelerate breakthroughs in #CellandGeneTherapy development: hubs.ly/Q03Pj3Tg0 #Autoimmune #GenderBias #AdvancedTherapies

BioIVT can provide #biospecimens from any commercially available species for a broad range of applications. Learn about the primary species, how they are collected & their role in research and therapeutic or diagnostic development: hubs.ly/Q03Pj3SF0

Due in part to the #FDA’s 2025 draft guidance on biopsy inclusion in #clinicaltrials, the #diagnostics community is increasingly turning to #LiquidBiopsy for minimally invasive screens to detect disease earlier: hubs.ly/Q03Pj9LW0

The work we do at BioIVT supports researchers developing tomorrow’s cures. But those researchers rely on real people, real donors, willing to share a blood sample to fuel that progress. Curious why people donate? Find out why: hubs.ly/Q03PjD3b0

Our final 2025 #ScienceArt release reimagines Pablo Picasso’s signature style through the lens of #CellAndGeneTherapy. Just as #Picasso challenged artistic norms, today’s researchers are challenging what’s possible in human health. Request a free print: hubs.ly/Q03PjD7Z0

Please join us in welcoming Yosra Zhang to BioIVT as a Technical Sales Specialist, Disease State, for North America East!

Visit us @ #Biomarkers & #PrecisionMedicine booth #19 to discuss how we can provide more relevant, quality #biospecimens to help ensure the accuracy of your research then catch our presentation @ 2:35pm discussing critical biomarker program considerations: hubs.ly/Q03QfsyB0

Join us to learn about using siRNA gene knockdown to inhibit enzyme activity for over two weeks and see comparisons of siRNA knockdown vs. chemical inhibitors for determining the fraction metabolized for specific isoforms as well as of off-target effects: hubs.ly/Q03QdSPc0

From rigorous donor screening & viral testing to disease-state data validation & regulatory oversight, our leukapheresis process is built for precision & trust. Learn how BioIVT provides safe, consistent, and high integrity #leukopaks at every step: hubs.ly/Q03Qg5pD0

We’re hosting symposium S06 at #ACTOX2025 in Phoenix on Nov. 17 entitled “Transitioning to the New ICH M12 Guideline on Drug-#DrugInteractions: Concepts and Implications” featuring presentations from Dr. Brian Ogilvie & other industry experts. Learn more: hubs.ly/Q03QcZT40

-Akadeum Life Science Life Science confirmed BioIVT’s LEUKOMAX #leukopaks routinely contain fewer red blood cells (RBCs) compared to competitors, resulting in better purity post-cell isolation, easier downstream processing, & reduced risk of RBC clumping. Learn more: hubs.ly/Q03QMtMp0

Our November Events Newsletter is out, featuring presentations on #DrugMetabolism for #LowTurnoverCompounds and the ICH M12 #DrugInteractions Guideline as well as events on #ADCs, #CancerImmunotherapy, #LiquidBiopsy, #Diagnostics, #CellTherapy and more: hubs.ly/Q03QPBXL0

For Andrea Wolff, the knowledge that organ donations like her sister’s could help advance life-saving drug research gives her work profound purpose. Ensuring safe and effective medicines isn’t just science, #ItsPersonal.